Therapeutics & Vaccines
RSV Virus-Like Particles And Methods Of Use Thereof
Inventors: Elizabeth Wright, Larry Anderson, Binh Ha
The present disclosure relates to vims-like particles and vaccine compositions for inducing immunity and preventing respiratory syncytial vims (RSV) infection. Specifically, the disclosure provides vims like-particles (VLPs) for use in inducing immunity to respiratory syncyhial vims (RSV) infections or symptoms thereof, wherein the VLP comprising a respiratory RSV matrix protein (M) and an RSV M2- l protein, a glycoprotein (G), a fusion protein (F), and/or a phosphoprotein (P).
For More Information About the Inventors